Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1101 of 6351
-
New staged treatment shows promise for preventing psychosis in At-Risk youth
Disease control CompletedA sequential multistage randomised clinical trial (SMART) to produce evidence to guide a step-wise clinical approach for the treatment of ultra high risk patients and reduction of risk for psychosis and other deleterious clinical and/or functional outcomes.
Phase 3 • Sponsor: Orygen • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Bone marrow tests may spot breast Cancer's hidden seeds
Knowledge-focused Recruiting nowThis is a single center, prospective cross-sectional study of women who have completed therapy for primary breast cancer within 5 years of diagnosis and are at increased risk for relapse. Patients will undergo screening bone marrow aspirate to test for presence of disseminated t…
Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Knowledge-focused
Last updated Aug 21, 2026 00:00 UTC
-
Gene therapy shot aimed at diabetic nerve pain put to the test
Symptom relief CompletedThe purpose of this study is to determine the safety and efficacy of bilateral intramuscular injections of VM202 versus placebo in the treatment of painful diabetic peripheral neuropathy. A total of 507 of 477 planned participants were randomized in a 2:1 ratio to one of two tre…
Phase 3 • Sponsor: Helixmith Co., Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC
-
Could one radiation session replace weeks of treatment for breast cancer?
Disease control OngoingRadiation, Stereotactic Body Radiation Therapy.
Phase 1 • Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
New drug combo may outperform chemo for returning ovarian cancer
Disease control OngoingThis phase III trial studies olaparib or cediranib maleate and olaparib to see how well they work compared with standard platinum-based chemotherapy in treating patients with platinum-sensitive ovarian, fallopian tube, or primary peritoneal cancer that has come back. Olaparib and…
Phase 3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
New immunotherapy cocktails aim to boost pancreatic cancer surgery success
Disease control OngoingThis platform trial will evaluate various immunotherapy combinations given in the neo-adjuvant and adjuvant setting in patients with surgically resectable pancreatic ductal adenocarcinoma.
Phase 2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New drug combo aims to wipe out rectal tumors before surgery
Disease control OngoingThe purpose of this study is to see how effective and safe LY2157299, in combination with chemotherapy and radiation therapy, might be in treating rectal cancer. Also as part of this study, research will be done on tumor samples to see if it is possible to predict if patients wil…
Phase 2 • Sponsor: Providence Health & Services • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New drug cocktail shows promise for leukemia patients
Disease control OngoingThis phase II trial studies how well ibrutinib, fludarabine phosphate, cyclophosphamide, and obinutuzumab work in treating patients with chronic lymphocytic leukemia. Ibrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Drugs used …
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
New drug cocktail shows promise for tough cancers
Disease control OngoingThe purpose of this study is to look at the effectiveness, safety, and antitumor activity of study drugs MEDI4736 in combination with olaparib (modules 1, 2, 3, 4, 5 and 7) and MEDI4736 in combination with olaparib and bevacizumab (module 6). It will also examine what happens to …
Phase 1/2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Half-Matched stem cell transplant offers hope for blood cancer patients
Disease control Recruiting nowNow haplo stem cell transplant using bone marrow or peripheral blood is becoming more feasible with better regimens to prevent graft versus host disease (GVHD) like post transplant cyclophosphamide , tacrolimus, mycophenolate . Recently Bortezomib has also been shown to inhibit d…
Phase 2 • Sponsor: Henry Ford Health System • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
New hope for leukemia patients who Can't tolerate standard treatment
Disease control OngoingA Phase 2 Study to evaluate the Efficacy and Safety of ACP-196 (acalabrutinib) in Subjects with Relapsed/Refractory CLL and Intolerant of Ibrutinib Therapy
Phase 2 • Sponsor: Acerta Pharma BV • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New chemo delivery method shows promise for tough mesothelioma cases
Disease control CompletedThe purpose of this study is to determine whether the transarterial chemoperfusion treatment with cisplatin, methotrexate and gemcitabine is safe and effective in adults with malignant pleural mesothelioma (MPM).
Phase 2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Immunotherapy duo takes on Hard-to-Treat brain tumors
Disease control OngoingThis research study is studying targeted immunotherapies as a possible treatment for recurrent meningioma. The names of the study interventions involved in this study are nivolumab and ipilimumab.
Phase 2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
New study: less invasive heart valve procedure as safe as surgery for Low-Risk patients
Disease control OngoingThe study objective is to demonstrate that the safety and effectiveness of the Medtronic TAVR system as measured by rates of all-cause mortality or disabling stroke at two years is noninferior to SAVR in the treatment of severe aortic stenosis in subjects who have a low predicted…
Sponsor: Medtronic Cardiovascular • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Zapping kidney nerves could tame tough blood pressure
Disease control OngoingRADIANCE-HTN is a randomized, double-blind, sham controlled, 2-cohort study (TRIO and SOLO) designed to demonstrate efficacy and document the safety of the Paradise Renal Denervation System in two distinct populations of hypertensive subjects.
Sponsor: ReCor Medical, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Blood test could replace needle biopsies for cancer diagnosis
Diagnosis Recruiting nowThe investigators aim to collect tumor DNA out of blood of cancer patients. If this is successful this could lead to the development of a cancer test in blood in the future, which is less invasive than current diagnostic methods.
Sponsor: Maastricht University Medical Center • Aim: Diagnosis
Last updated Jun 27, 2026 07:53 UTC
-
New heart valve procedure could change treatment for aortic stenosis patients
Disease control OngoingTo establish the safety and effectiveness of the Edwards SAPIEN 3 Transcatheter Heart Valve (THV) in patients with severe, calcific aortic stenosis who are at low operative risk for standard aortic valve replacement.
Sponsor: Edwards Lifesciences • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Can a simple dye help surgeons see brain tumors in real time?
Diagnosis OngoingThis clinical research will evaluate the diagnostic potential of fluorescein as visualized through an operating microscope relative to 1) contrast enhancement on co-registered preoperative MR scans, 2) intraoperative ALA-induced PpIX fluorescence and 3) gold-standard histology ob…
Phase 2 • Sponsor: David W. Roberts • Aim: Diagnosis
Last updated Jul 31, 2026 00:00 UTC
-
Bringing HIV care to the community: a new test in zambia
Disease control CompletedThis study seeks to create generalizable knowledge about the implementation process as well as the effectiveness and efficiency of a differentiated care system, by measuring patient health outcomes and implementation outcomes such as acceptability, feasibility, fidelity, and cost…
Sponsor: Centre for Infectious Disease Research in Zambia • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
New chemo cocktail shows promise for rare, aggressive breast cancer
Disease control OngoingThis research study is studying a drug called eribulin combined with standard treatment as a possible preoperative treatment for HER2 negative inflammatory breast cancer.
Phase 2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC